[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346690-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346690-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","role-of-solute-carrier-family-7-member-7-in-cancer-opportunities-for-tumor-microenvironment-research","Role of solute carrier family 7 member 7 in cancer - opportunities for tumor microenvironment research","","Cancer poses serious health risks, and solute carrier (SLC) family members regulate cancer development and tumor microenvironment (TME) formation. SLC7A7, a key SLC7 member, forms a heterodimer with SLC3A2 to transport cationic and neutral amino acids, sustaining cellular amino acid homeostasis. Recent work resolves SLC7A7 structure, maps residues for substrate binding, and supports small-molecule inhibitor development. Studies also describe expression regulation across human, mouse, and porcine cells, linking dysregulated SLC7A7 to proliferation, metastasis, and immune escape via TME immune-cell modulation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-of-solute-carrier-family-7-member-7-in-cancer-opportunities-for-tumor-microenvironment-research/346690/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-of-solute-carrier-family-7-member-7-in-cancer-opportunities-for-tumor-microenvironment-research/346690.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What function does SLC7A7 perform in cancer-related processes?","Question",{"text":63,"@type":64},"SLC7A7 forms an obligate heterodimer with SLC3A2 to transport cationic and neutral amino acids across membranes, maintaining amino acid homeostasis. Dysregulation of SLC7A7 is linked to cancer proliferation and metastasis and contributes to shaping the tumor microenvironment (TME).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does structural information about SLC7A7 support future drug development?",{"text":68,"@type":64},"A recent study resolved the crystal structure of SLC7A7 and identified key residues involved in substrate binding. These experimental insights provide evidence for developing small-molecule inhibitors targeting SLC7A7.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is SLC7A7 considered important for immune escape in the TME?",{"text":72,"@type":64},"The review emphasizes that SLC7A7 promotes cancer immune escape by influencing both innate and adaptive immune cells in the TME. It discusses mechanisms such as macrophage polarization, T-cell exhaustion, and disruption of the Th17/Treg balance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346690,1790176322,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Open access Review  \n Role of solute carrier family 7 member 7  \nin cancer: opportunities for tumor microenvironment research  \nZhentao Zhang  , Jiani Lv, Jiang Li   \nTo cite: Zhang Z, Lv J, Li J. Role of solute carrier family 7 member 7 in cancer:  \nopportunities for tumor microenvironment research. Journal for ImmunoTherapy of Cancer 2026;14:e014658 . doi:10.1136/jitc-2025-014658  \nAccepted 21 February 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nDepartment of Pharmacy, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China  \nCorrespondence to  \nJiang Li;  \n[20163415@zcmu.edu.cn](20163415@zcmu.edu.cn)  \nABSTRACT  \nCancer poses serious health risks to humans. The solute carrier (SLC) family is crucial for cancer development regulation. As a member of this family, SLC7A7 forms a heterodimer with SLC3A2 to transport cationic and neutral amino acids (AA) across the membrane, thereby maintaining cellular AA homeostasis. A recent study resolved the crystal structure of SLC7A7 and identified the key residues involved in substrate binding of SLC7A7, providing important experimental evidence for the future development of small-molecule inhibitors of SLC7A7 . In addition, multiple studies have revealed the expression regulation mechanism of SLC7A7 in human, mouse, and porcine cells, providing a basis for studying the regulatory mechanism of SLC7A7 expression in cancer cells. SLC7A7 is dysregulated in multiple cancers, including bladder cancer, non-small cell lung cancer, and hepatocellular carcinoma. SLC7A7 is involved in cancer proliferation and metastasis, with a notable impact on shaping the tumor microenvironment (TME) across multiple cancer types, making it a valuable target for further investigation. In this review, we discuss recent advances in understanding the structure, expression, and regulatory mechanisms of SLC7A7, focusing on its role in cancer development and the current research limitations. Furthermore, this review emphasizes the role of SLC7A7 in promoting cancer immune escape by influencing innate and adaptive immune cells in the TME and discusses its potential mechanisms of immune cell regulation.  \nINTRODUCTION  \nCancer is a major global challenge exerting profound societal, public health, and economic impacts worldwide.1 The tumor microenvironment (TME) regulates cancer initiation, progression, and therapeutic responses. It constitutes a complex ecosystem composed of diverse cellular components, such as tumor-associated macrophages (TAMs), cancer-associated fibroblasts, and other infiltrating immune cells, alongside non-cellular elements, including the extracellular matrix, cytokines, and angiogenic mediators. Through dynamic interactions, these components collectively facilitate immune evasion, stromal remodeling, and neovascularization, driving malignancy and treatment  \nresistance.2 The reprogramming of cellular metabolism and establishment of an immunosuppressive TME are hallmarks of cancer that are increasingly recognized to be intimately linked.3 Solute carriers (SLCs), the largest family of membrane transporters, are located at the interface of these processes, governing nutrient fluxes that fuel cancer growth and shape the metabolic landscape ofthe TME.4 5 Some SLCs, such as SLC7A5 (LAT1), have garnered significant attention for their roles in supplying amino acids (AAs) to support oncogenic signaling and shape TME,6 7 the functions of many other SLC members in orchestrating tumor-immune crosstalk remain underexplored. SLC7A7 (y+LAT1), which shares high structural homology with SLC7A5 and forms an obligatory heterodimer with SLC3A2 (4F2hc) for membrane localization, has a distinct substrate profile  \nand transport mechanism.8 9 However, the implications of SLC7A7 in cancer biology extend far beyond mere n","cbCaivHFbaspAWhT","https://ap.wps.com/l/cbCaivHFbaspAWhT","pdf",6338588,12,"English","# Abstract\n# Introduction\n## Tumor microenvironment and metabolic reprogramming\n## SLC7A7 biology and cancer relevance\n# Biology of SLC7A7\n## Gene, structure, and expression of SLC7A7\n# Table 1 Key residues in SLC7A7 for amino acid or Na+ binding","[{\"question\":\"What function does SLC7A7 perform in cancer-related processes?\",\"answer\":\"SLC7A7 forms an obligate heterodimer with SLC3A2 to transport cationic and neutral amino acids across membranes, maintaining amino acid homeostasis. Dysregulation of SLC7A7 is linked to cancer proliferation and metastasis and contributes to shaping the tumor microenvironment (TME).\"},{\"question\":\"How does structural information about SLC7A7 support future drug development?\",\"answer\":\"A recent study resolved the crystal structure of SLC7A7 and identified key residues involved in substrate binding. These experimental insights provide evidence for developing small-molecule inhibitors targeting SLC7A7.\"},{\"question\":\"Why is SLC7A7 considered important for immune escape in the TME?\",\"answer\":\"The review emphasizes that SLC7A7 promotes cancer immune escape by influencing both innate and adaptive immune cells in the TME. It discusses mechanisms such as macrophage polarization, T-cell exhaustion, and disruption of the Th17/Treg balance.\"}]","Role of solute carrier family 7 member 7 in cancer - opportunities for tumor microenvironment research | PDF",1790062424,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/171dcfee0188526b65472403594610b3.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3908bbf39196cdee7e891203ca9f636e.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcffb75ae6512118d249df70b043369b.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b11b32fe7b9b0659b39f053657b1fbe.webp",980,1306]